Does Antidepressant Therapy Improve Cognition in Elderly Depressed Patients?

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 58, Issue 12, 2003, Pages 1137-1144

  Doraiswamy, P Murali ^a   Krishnan, K Ranga Rama ^a   Oxman, Thomas ^b   Jenkyn, Lawrence R ^b   Coffey, David J ^b   Burt, Tal ^c   Clary, Cathryn M ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; NORTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; ANTICHOLINERGIC EFFECT; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; COGNITION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; MOTOR PERFORMANCE; MULTICENTER STUDY; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; XEROSTOMIA;

EID: 0346250894     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/58.12.m1137     Document Type: Article

References (46)

1. Niederehe G, Burt DB, Zembar MJ. Depression and memory impairment: a meta-analysis of the association, its pattern, and specificity. Psychol Bull. 1995;117:285-305.
2. Boone KB, Lesser I, Miller B, et al. Cognitive functioning in a mildly to moderately depressed geriatric sample: relationship to chronological age. J Neuropsychiatry Clin Neurosci. 1994;6:267-272.
3. Alexopoulos GS, Meyers BS, Young RC, et al. Executive dysfunction and long-term outcomes of geriatric depression. Arch Gen Psychiatry. 2000;57:285-290.
4. Lesser IM, Boone KB, Mehringer CM, et al. Cognition and white matter hyperintensities in older depressed patients. Am J Psychiatry. 1996;153:1280-1287.
5. Nebes RD, Butters MA, Mulsant BH, et al. Decreased working memory and processing speed mediate cognitive impairment in geriatric depression. Psychol Med. 2000;30:679-691.
6. Sobin C, Sackeim HA. Psychomotor symptoms of depression. Am J Psychiatry. 1997;154:4-17.
7. Steffens DC, Krishnan KR. Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol Psychiatry. 1998;43:705-712.
8. Alexopoulos GS, Meyers BS, Young RC, et al. "Vascular depression" hypothesis. Arch Gen Psychiatry. 1997;54:915-922.
9. Nobler MS, Pelton GH, Sackeim HA. Cerebral blood flow and metabolism in late-life depression and dementia. J Geriatr Psychiatry Neurol. 1999;12:118-127.
10. Meltzer CC, Smith G, DeKosky ST, et al. Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacol. 1998;18:407-430.
11. Park SB, Coull JT, McShane RH, Young AH, Sahakian BJ, Robbins TW, Cowen PJ. Tryptophan depletion in normal volunteers produces selective impairments in learning and memory. Neuropharmacology. 1994;34:575-588.
12. Herremans AHJ, Hijzwn TH, Olivier B, Slangen JL. Serotonergic drug on a delayed conditional discrimination task in the rat: involvement of the 5-HT-sub(1A) receptor in working memory. J Psychopharmacol. 1995;9:242-250.
13. Richter-Levin G, Segal M. Serotonin, aging and cognitive functions of the hippocampus. Rev Neurosci. 1996;7:103-113.
14. Riedel WJ, Klaassen T, Deutz NE, van Someren A, Praag HM. Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacol. 1999;141:362-369.
15. Steckler T, Shagal A. The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour. Behav Brain Res. 1995;67:165-199.
16. Kalayam B, Alexopoulos GS. Prefrontal dysfunction and treatment response in geriatric depression. Arch Gen Psychiatry. 1999;56:713-718.
17. Knegtering H, Eijck M, Huijsman A. Effects of antidepressants on cognitive functioning of elderly patients. A review. Drugs Aging. 1994;5:192-199.
18. Meyers BS, Mattis S, Gabriele M, Kakuma T. Effects of nortriptyline on memory self-assessment and performance in recovered elderly depressives. Psychopharmacol Bull. 1991;27:295-299.
19. Young RC, Mattis S, Alexopoulos GS. et al. Verbal memory and plasma drug concentrations in elderly depressives treated with nortriptyline. Psychopharmacol Bull. 1991;27:291-294.
20. Georgotas A, McCue RE, Reisberg B, et al. The effects of mood changes and antidepressants on the cognitive capacity of elderly depressed patients. Int Psychogeriatr. 1989;1:135-143.
21. Teri L, Reifler BV, Veith RC, et al. Imipramine in the treatment of depressed Alzheimer's patients: impact on cognition. J Gerontol. 1991;46:P372-P377.
22. Fairweather DB, Kerr JS, Hilton S, Hindmarch I. A placebo controlled double-blind evaluation of the pharmacodynamics of fengabine vs amitriptyline following single and multiple doses in elderly volunteers. Br J Clin Pharmacol. 1993;35:278-283.
23. Nebes RD, Pollock BG, Mulsant BH, et al. Cognitive effects of paroxetine in older depressed patients. J Clin Psychiatry. 1999;60(Suppl 20):26-29.
24. Geretsegger C, Bohmer F, Ludwig M. Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects. Int Clin Psychopharmacol. 1994;9:25-29.
25. Schone W, Ludwig M. A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression. J Clin Psychopharmacol. 1993;13(6 Suppl 2):34S-39S.
26. Nebes RD, Pollock BG, Mulsant BH, Butters MA, Zmuda MD, Reynolds CF 3rd. Cognitive effects of paroxetine in older depressed patients. J Clin Psychiatry. 1999;60(Suppl 20):26-29.
27. Podewils LJ, Lyketsos CG. Tricyclic antidepressants and cognitive decline. Psychosomatics. 2002;43:31-35.
28. Fairweather DB, Kerr JS, Hilton S, Hindmarch I. A placebo controlled double-blind evaluation of the pharmacodynamics of fengabine vs amitriptyline following single and multiple doses in elderly volunteers. Br J Clin Pharmacol. 1993;35:278-283.
29. Kerr JS, Fairweather DB, Mahendran R, Hindmarch I. The effects of paroxetine, alone and in combination with alcohol on psychomotor performance and cognitive function in the elderly. Int Clin Psychopharmacol. 1992;7:101-108.
30. Lane RM, O'Hanlon JF. Cognitive and psychomotor effects of antidepressants with emphasis on selective serotonin reuptake inhibitors and the depressed elderly patient. German J Psychiatry. 1999;2:1-28.
31. Bondareff W, Alpert M, Friedhoff AJ, et al. Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life. Am J Psychiatry. 2000;157:729-736.
32. Newhouse PA, Krishnan KR, Doraiswamy PM, et al. A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients. J Clin Psychiatry. 2000;61:559-568.
33. Butters MA, Becker JT, Nebes RD, et al. Changes in cognitive functioning following treatment of late-life depression. Am J Psychiatry. 2000;157:1949-1954.
34. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278-279.
35. Guy W, ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: U.S. Department of Health, Education and Welfare; 1976, ADM 76-338:218-222.
36. Buschke H, Fuld PA. Evaluating storage, retention and retrieval in disordered memory and learning. Neurology. 1974;24:1019-1025.
37. McCarthy M, Ferris SH, Clark E, Crook T. Acquisition and retention of categorized material in normal aging and senile dementia. Exp Aging Res. 1981;7:127-135.
38. Wechsler D. Wechsler Adult Intelligence Scale-Revised. Psychological Corporation; 1981
39. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Rev. 1975;12:189-198.
40. Oxman TE. Antidepressants and cognitive impairment in the elderly. J Clin Psychiatry. 1996;57(Suppl 5):38-44.
41. Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288:701-709.
42. Kimura M, Robinson RG, Kosier JT. Treatment of cognitive impairment after post-stroke depression: a double blind treatment trial. Stroke. 2000;31:1048-1049.
43. Fann JR, Uomoto JM, Katon WJ. Cognitive improvement with treatment of depression following mild traumatic brain injury. Psychosomatics. 2001;42:48-54.
44. Nathan PJ, Sitaram G, Stough C, Silberstein RB, Sali A. Serotonin, noradrenaline and cognitive function: a preliminary investigation of the acute pharmacodynamic effects of a serotonin versus a serotonin and noradrenaline reuptake inhibitor. Behav Pharmacol. 2000;11:639-642.
45. Furlan PM, Kallan MJ, Ten Have T, Pollock BG, Katz I, Lucki I. Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteers. Am J Geriatr Psychiatry. 2001;9:429-438.
46. Schmitt JA, Kruizinga MJ, Riedel WJ. Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors. J Psychopharmacol. 2001;15:173-179.